- Home
- JVA vs AYTU Comparison
JVA vs AYTU Comparison
Compare JVA & AYTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JVA
- AYTU
- Stock Information
- Founded
- JVA 1971
- AYTU N/A
- Country
- JVA United States
- AYTU United States
- Employees
- JVA N/A
- AYTU N/A
- Industry
- JVA Packaged Foods
- AYTU Biotechnology: Pharmaceutical Preparations
- Sector
- JVA Consumer Staples
- AYTU Health Care
- Exchange
- JVA Nasdaq
- AYTU Nasdaq
- Market Cap
- JVA N/A
- AYTU 9.8M
- IPO Year
- JVA 2005
- AYTU N/A
- Fundamental
- Price
- JVA $3.68
- AYTU $1.38
- Analyst Decision
- JVA
- AYTU
- Analyst Count
- JVA 0
- AYTU 0
- Target Price
- JVA N/A
- AYTU N/A
- AVG Volume (30 Days)
- JVA 162.6K
- AYTU 37.1K
- Earning Date
- JVA 02-07-2025
- AYTU 02-12-2025
- Dividend Yield
- JVA N/A
- AYTU N/A
- EPS Growth
- JVA N/A
- AYTU N/A
- EPS
- JVA 0.20
- AYTU N/A
- Revenue
- JVA $76,111,698.00
- AYTU $79,759,000.00
- Revenue This Year
- JVA N/A
- AYTU N/A
- Revenue Next Year
- JVA N/A
- AYTU N/A
- P/E Ratio
- JVA $18.10
- AYTU N/A
- Revenue Growth
- JVA 17.27
- AYTU N/A
- 52 Week Low
- JVA $0.81
- AYTU $1.30
- 52 Week High
- JVA $4.66
- AYTU $3.45
- Technical
- Relative Strength Index (RSI)
- JVA 47.99
- AYTU 33.90
- Support Level
- JVA $3.92
- AYTU $1.30
- Resistance Level
- JVA $4.66
- AYTU $1.47
- Average True Range (ATR)
- JVA 0.40
- AYTU 0.12
- MACD
- JVA -0.07
- AYTU -0.01
- Stochastic Oscillator
- JVA 22.22
- AYTU 17.78
About AYTU Aytu BioPharma Inc.
Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.